ArticleArchives of toxicology2026
ToxiGuard: an AOP-guided mechanistically interpretable framework for multi-organ toxicity prediction.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of organ-specific toxicity with mechanistic interpretability remains a central challenge in chemical safety assessment and translational toxicology. Although animal-based assays provide biologically relevant information, they are low throughput and increasingly constrained by ethical and regulatory considerations. In parallel, data-driven computational approaches-particularly deep learning-have achieved strong predictive performance but often lack transparency, limiting their utility for mechanistic interpretation and regulatory decision-making. Here, we present ToxiGuard, a mechanistically informed deep learning framework that embeds organ-specific Adverse Outcome Pathway (AOP) structures directly into the model architecture. By explicitly encoding Molecular Initiating Event-Key Event-Adverse Outcome (MIE-KE-AO) connectivity, ToxiGuard constrains representation learning to biologically plausible causal pathways rather than relying solely on post hoc explanation. The framework integrates molecular descriptors, functional-class fingerprints, and curated AOP networks to enable complementary interpretability at both chemical and biological levels. Across four organ toxicity endpoints-hepatotoxicity, cardiotoxicity, nephrotoxicity, and respiratory toxicity-ToxiGuard demonstrates robust and consistent predictive performance, outperforming traditional machine learning models and AOP-agnostic neural network baselines. SHAP-based analyses reveal concentrated contributions from specific physicochemical properties, molecular substructures, and mechanistic AOP components, including CAR/PXR-associated pathways in hepatotoxicity and hERG-related mechanisms in cardiotoxicity. These findings are consistent with established toxicological knowledge and support the biological plausibility of model predictions. Overall, this study demonstrates that embedding mechanistic toxicological structure into deep learning architectures can enhance both predictive reliability and interpretability. ToxiGuard provides a transparent, AOP-anchored computational approach that complements existing experimental and in silico methods for early-stage organ toxicity assessment and chemical safety evaluation.
Indexed as
Identifiers
42159741What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.